AngioSoma, Inc. is a wellness company, which engages in the manufacture and marketing of pharmaceuticals and nutraceutical supplements. It also develops Liprostin for the treatment of peripheral artery disease. The company was founded by David P. Summers on April 29, 2016 on and is headquartered in Houston, TX.
Company profile
Ticker
GSTC
Exchange
Website
CEO
Alexanderia K. Blankenship
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
AngioSoma, Inc., First Titan Corp.
SEC CIK
Corporate docs
Subsidiaries
SomaCeuticals, Inc. • First Titan Energy, LLC • First Titan Technical, LLC ...
GSTC stock data
Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
11 Mar 24
NT 10-Q
Notice of late quarterly filing
15 Feb 24
10-K
2023 FY
Annual report
19 Jan 24
NT 10-K
Notice of late annual filing
2 Jan 24
8-K
Other Events
13 Nov 23
10-Q
2023 Q3
Quarterly report
17 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
8-K
Changes in Registrant's Certifying Accountant
27 Jun 23
8-K
Globestar Therapeutics Enters into Mou with Advanced Innovative Partners to Develop Clinical Studies for Multiple Sclerosis Treatment
22 Jun 23
10-Q
2023 Q2
Quarterly report
30 May 23
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 23 | Sep 22 | Sep 21 | Sep 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | ||||||
Cash burn (monthly) | (no burn) | 530.42 | 95.93 k | 155.36 k | 24.23 k | 17.15 k |
Cash used (since last report) | n/a | 3.65 k | 659.48 k | 1.07 mm | 166.58 k | 117.88 k |
Cash remaining | n/a | -3.65 k | -659.48 k | -1.07 mm | -166.58 k | -117.88 k |
Runway (months of cash) | n/a | -6.9 | -6.9 | -6.9 | -6.9 | -6.9 |
Institutional ownership, Q4 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|